The potency of therapeutic CCNE1 inhibition on parenchymal tumour cell growth, stemness and invasion capacity should therefore be first addressed in 3D culture systems such as tumour spheres, hydrogel microspheres or organoids of hepatoma cells or patient-derived xenograft. This evidence concerns the gene CCNE1 and hepatocellular carcinoma.